Menu

Close

Here's the text.

About Ebola hemorrhagic fever, Middle East Respiratory Syndrome (MERS)

Last Updated March 28, 2024

What is Ebola hemorrhagic fever?

Characteristics of Ebola hemorrhagic fever
Cause   Ebolavirus
Route of infectionWhen the body fluids (blood, secretions, vomit / excretion) of a patient with symptoms are touched without sufficient protection, the virus enters through wounds and mucous membranes and is transmitted.
It is also transmitted from wild animals in endemic areas.
In general, it is not transmitted from asymptomatic patients and there is no airborne infection.
Area of occurrenceGuinea, Sierra Leone, Liberia, Uganda, Sudan, Gabon, Côte d'Ivoire, Democratic Republic of Congo, Republic of the Congo
SymptomsAfter an incubation period of 2 to 21 days (usually 7 to 10 days), symptoms such as sudden fever, headache, malaise, muscle pain, and sore throat appear.

Prevention
Treatment

Currently, there are no vaccines or specific treatments. It provides symptomatic treatment according to the patient's symptoms.
  • Since March 2014, large-scale outbreaks have occurred in Guinea, Liberia, Sierra Leone, Mali, and Nigeria in western Africa.

Middle East Respiratory Syndrome (MERS)

Characteristics of Middle East Respiratory Syndrome (MERS)
Cause   MERS coronavirus (first confirmed in 2012)
Route of infectionIt is still unclear exactly how humans become infected.
Dromedary camels are said to be a type of animal that is transmitted to the MERS virus, but on the other hand, many patients have no history of contact with animals. Infections have also been reported between close contacts, such as between families, between patients at medical institutions where infection control is inadequate, and between patients and healthcare professionals.
Area of occurrenceUnited Arab Emirates, Yemen, Oman, Qatar, Kuwait, Saudi Arabia, Jordan
SymptomsAfter an incubation period of about 2 to 14 days, most patients develop pneumonia due to fever and severe respiratory symptoms. Some patients may be mildly ill or their findings may be atypical.

Prevention
Treatment

Currently, there are no vaccines or specific treatments. It provides symptomatic treatment according to the patient's symptoms.

To the citizens

 If it is unavoidable to travel to the affected area, check the status of local epidemics in the Ministry of Health, Labour and Welfare's Quarantine Station FORTH "Countries and Regions" (external site) and the Ministry of Foreign Affairs' "Overseas Safety Information" (external site), and consider whether or not to travel, and take basic hygiene measures (hand washing, avoid contact with patients and animals, etc.).
 If you experience symptoms after traveling to the affected area or contacting an infected person, please do not consult a medical institution directly and contact Health Promotion Section Health and Welfare Center, Health and Welfare Division, in each district.                                         
※In case of emergency other than weekday business hours, please contact the Yokohama City Public Health Center Infectious Disease Food Poisoning Emergency Call Dial. Please refrain from contacting us if there is no urgency for emergency use during night holidays.

To Medical Institutions

Related Sites

Ebola hemorrhagic fever


 

Middle East Respiratory Syndrome (MERS)

You may need a separate PDF reader to open a PDF file.
If you do not have it, you can download it free of charge from Adobe.
Get Adobe Acrobat Reader DCTo download Adobe Acrobat Reader DC

Inquiries to this page

Health and Safety Division, Medical Care Bureau Health and Safety Department

Telephone: 045-671-2463

Telephone: 045-671-2463

Fax: 045-664-7296

Email address: ir-kenkoanzen@city.yokohama.jp

Return to the previous page

Page ID: 592-378-795

Menu

  • LINE
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • SmartNews